Embody vs Noom Med: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
Noom Med beats Embody overall, scoring 7.4/10 vs 7.3/10. Embody is more affordable at $69/mo vs $79/mo. Choose Embody for people who want the oral tirzepatide gum, or who want the ch. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring an.
A side-by-side look at Embody and Noom Med to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Embody
#34 of 53Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Injectable pricing went flat on July 31, 2026: $69/mo for compounded semaglutide and $119/mo for compounded tirzepatide, with no long term commitment, replacing an older promo plan that stepped up after month 1. Their standout: oral tirzepatide gum, for people who don't want to inject.
Visit EmbodyNoom Med
#25 of 53Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom Med| Feature | Embody | Noom Med |
|---|---|---|
| Why each one | One of the few GLP-1 providers offering oral tirzepatide as a chewable gum, a real choice for people who don't want injections. | The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change. |
| Our Score | 7.3/10 | 7.4/10 |
| Starting Price | $69/mo | $79/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | Yes |
| Best For | People who want the oral tirzepatide gum, or who want the cheapest flat month-to-month tirzepatide injection we track at $119/mo | Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing |
| Watch out for | The $69 and $119 flat prices are new as of July 31, 2026 and replace a promo plan that stepped up to $249 to $399 after month 1. Embody says you lock the flat rate in, but we have verified what the signup page advertises, not how billing behaves months later. Screenshot your checkout price. | Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27] |
| Ranking | #34 | #25 |
| Get started | Visit Embody | Visit Noom Med |
Pros & Cons Compared
Embody
Pros
- +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
- +Flat $69/mo semaglutide and $119/mo tirzepatide, verified July 31, 2026. The $119 is the cheapest flat month-to-month tirzepatide on the site, under TMates at $167/mo.
- +No long term commitment on either flat plan. Embody frames the new rate as $230 off every month against the old $299/mo price, now struck through on its own signup page.
- +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −The $69 and $119 flat prices are new as of July 31, 2026 and replace a promo plan that stepped up to $249 to $399 after month 1. Embody says you lock the flat rate in, but we have verified what the signup page advertises, not how billing behaves months later. Screenshot your checkout price.
- −Trustpilot rating is 3.6 / 5 across 3,869 reviews, verified July 25, 2026, and 3,854 of those were left in the last 12 months. Price is the top complaint theme, most of it tied to the promo-to-flat switchover Embody has since replaced.
- −Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' Non-disclosure is the norm among the compounded programs whose pharmacy sourcing we have checked: Henry Meds, Yucca Health and Eden Health name no facility either. Telos RX and HealthRX are the exceptions we found, and both disclose only the 503A category rather than a facility name. Ask Embody's support directly if provenance matters to you.
- −No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
- −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.
Noom Med
Pros
- +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
- +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
- −App coaching still requires real engagement, skip-prone users waste the behavioral value
Our Verdict
Noom Med edges out Embody with a score of 7.4/10 vs 7.3/10. If budget is your priority, Embody is a flat $69/mo compared to Noom Med at $79/mo for the first month, then $199/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Noom Med offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who want the cheapest flat month-to-month tirzepatide injection we track at $119/mo. Choose Noom Med if you want: users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing.
Read Full Reviews
Related comparisons
Other matchups readers comparing Embody or Noom Med tend to look at next.
- Embody vs Strut Health$99/mo
- Embody vs HealthRX$99/mo
- Embody vs TrimRx$179/mo
- Noom Med vs WeightWatchers (Sequence)$74/mo
- Noom Med vs Sprout Health$199/mo
- Noom Med vs Enhance MD$212/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Noom Med · 7.4/10